Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma

Author： Tacconelli Antonella   Farina Antonietta R   Cappabianca Lucia   Gulino Alberto   Mackay Andrew R  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.1, Iss.5, 2005-10, pp. : 689-698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal antibody to human trk-A: diagnostic and therapeutic potential in neuroblastoma

By Kramer K.   Gerald W.   LeSauteur L.   Saragovi H.U.   Cheung N.-K.V.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2090-2091

Elsevier

Access to resources Recommend Favorite

TNF: a tumor-suppressing factor or a tumor-promoting factor?

By Balkwill Fran   Joffroy Christian  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1833-1836

Future Medicine

Access to resources Recommend Favorite

Rab15 alternative splicing is altered in spheres of neuroblastoma cells

By                                      

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 2045-2049

Spandidos Publications

Access to resources Recommend Favorite

Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment

By Owusu Benjamin Yaw   Galemmo Robert   Janetka James   Klampfer Lidija  

Cancers, Vol. 9, Iss. 4, 2017-04 ,pp. : 35-35

MDPI

Access to resources Recommend Favorite

Emetine regulates the alternative splicing of caspase 9 in tumor cells

By        

Oncology Letters, Vol. 2, Iss. 6, 2011-01 ,pp. : 1309-1312

Spandidos Publications

Access to resources Recommend Favorite